Cementless Partial Knee Implants Market – By Implant Type, By Material, By End Use - Global Forecast, 2025 - 2034

Cementless Partial Knee Implants Market Size

The global cementless partial knee implants market was valued at USD 789.7 million in 2024. The market is expected to reach USD 826.4 million in 2025 to USD 1.3 billion in 2034, growing at a CAGR of 5.5% during the forecast period. The high market growth is attributed to the rising infection rates contributing to a rise in knee revisions, increasing prevalence of osteoarthritis and rheumatoid arthritis, and growing preference for minimally invasive procedures.
 

The rising prevalence of osteoarthritis in the active and ageing population is one of the major factors fueling the market growth. According to a study conducted by The Lancet Rheumatology in 2021, 595 million people globally had osteoarthritis, with the knee joint being the most commonly impacted site. Cementless partial knee replacements are less invasive due to preserving healthy bone and ligaments, leading to quicker recovery and improved mobility compared to total knee replacement.
 

Furthermore, only the impaired section of the knee is treated in partial knee replacements. When performed through minimally invasive techniques, procedures tend to preserve more of the patient’s natural bone and ligaments, which improves post-operative mobility and makes the knee feel more natural. In addition, the design that eliminates the use of cement enhances biological fixation, which improves bone integration and, consequently, may increase the lifespan of the implant and circumvent certain complications associated with the application of bone cement.
 

Cementless partial knee implants are orthopedic devices used in unicompartmental knee arthroplasty (UKA) procedures where only one compartment of the knee joint (typically medial or lateral) is replaced without the use of bone cement to fix the implant components to the bone.
 

Cementless Partial Knee Implants Market Trends

The ongoing development of implant materials is aiding in unlocking growth opportunities for the market of cementless partial knee implants.
 

• Cementless modern smart implants are manufactured using titanium alloys, cobalt chromium, and other metals with a high degree of porosity. Cementless implants help encourage osseointegration, the biological process whereby bone directly integrates with the implant, removing the need for bone cement. This reduces the risk of inflammation resulting from cement debris and aseptic loosening.
   
• The bioactive surface coatings and plasma spray with porous structures help to better interface with living tissues, thus fostering improved biology. Rehabilitation assists patients who are able to actively participate; the quick recuperation for the active population and young patients is a boon.
   
• Clinically, there is now an adaptable option for the partially knee-installed versions that can be relied on as the changes made have resulted in improved patient satisfaction, as ranging motions, comfort, and mobility have markedly improved. Advanced materials have enabled anatomical design changes that make implants lighter while mimicking the natural biomechanics of joints.
   

Cementless Partial Knee Implants Market Analysis

Based on implant type, the market is segmented as fixed-bearing implants, mobile-bearing implants, medial pivot implants, and other implant types. The fixed-bearing implants segment is expected to drive business growth and expand at a CAGR of 5.3%, reaching over USD 876.2 million by 2034.
 

• Fixed-bearing devices are mechanically simpler than mobile-bearing systems, so they have less potential for mechanical failure. This makes them more popular among surgeons. Well-placed fixed-bearing implants have long-term survival rates of over 90% at 10 years, particularly in elderly, low-demand patients.
   
• In addition, mobile-bearing systems are usually more expensive than fixed-bearing systems because of greater complexity and additional components. The increased cost and complexity of mobile-bearing systems do not compensate for the decreased performance, which tends to limit their acceptance. Many orthopedic surgeons are trained in fixed-bearing systems, which accelerates their adoption, enhancing cost efficiency and overall system budget.
   

Based on material, the cementless partial knee implants market is segmented as titanium-based, cobalt-chromium alloys, polyethylene components, and other materials. The titanium-based segment is expected to drive business growth and expand at a CAGR of 5.4%, reaching over USD 781.8 million by 2034.
 

• Titanium’s biocompatibility aids in osseointegration, which is necessary for cementless implants where bone growth is required for implant integration. Compared to cobalt-chromium alloys, titanium implants have better adhesion with bone tissue and, therefore, greater resistance to loosening, which enhances the lifespan and stability of the implant.
   
• Titanium alloys have a greater strength-to-weight ratio and are, therefore, much lighter and also are not mechanically inferior to cobalt-chrome implants. This is advantageous for younger and active populations, like those undergoing partial knee replacements, who need ease of movement and comfort following the procedure.
   
• Furthermore, these implants are appropriate for individuals suffering from hypersensitivity to metals, increasing the demand for titanium implants in cases of personalized knee arthroplasty to mitigate immune reaction risks.

Based on end use, the cementless partial knee implants market is classified into hospitals, orthopedic centres, and other end users. The hospitals segment dominated the market with a revenue share of 59.9% in 2024.
 

• These institutions are usually the first to adopt new and innovative surgical procedures and implant technologies, thus making them a preferred site for cementless partial knee and other procedures.
   
• Modern operating and imaging facilities located in hospitals assist in better surgical planning and execution. This is important for the proper alignment and adaptation of cementless implants that depend on accurate placement and bone integration. In addition, many hospitals participate in or conduct clinical research and trials, which accelerates the adoption of newer advanced materials and designs for implants.
   
• Moreover, hospitals deal with a large patient population, especially elderly patients and those with co-existing medical problems, which makes them busy centers for orthopedic surgeries like partial knee replacement. Their ability to perform simple and complex cases consecutively leads to improved surgical and resource efficiency, which enhances the use of cementless implants.

The U.S. cementless partial knee implants market was valued at USD 324.9 million and USD 333.3 million in 2021 and 2022, respectively. The market size reached USD 353.7 million in 2024, growing from USD 343.1 million in 2023.
 

• The U.S. has one of the fastest demographic aging shifts in the world. As noted earlier, osteoarthritis of the knee, especially medial unicompartmental osteoarthritis, is a common problem in the elderly and remains one of the most frequent reasons for undertaking a partial knee replacement. For instance, as per a recent report published in Science Direct, there have been approximately 32.5 million cases of osteoarthritis in U.S. adults aged 18 and above in the year 2023.
   
• Additionally, there has been a noteworthy increase in outpatient orthopedic surgical procedures performed in the U.S. Ambulatory surgical centres routinely perform cementless partial knee replacements because of a historically good patient turnover due to shorter anesthesia times, minimal intraoperative blood loss, and postoperative recovery time.
   
• Further, the U.S. benefits from a well-established reimbursement infrastructure, with major private insurers and Medicare increasingly recognizing the cost-effectiveness of partial knee replacements over total knee replacements for appropriate cases.
   

Europe cementless partial knee implants market accounted for USD 156.3 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Europe's orthopedic frameworks are advanced, accompanied by a favorable demographic shift of a significant aging population, increasing partially cementless knee implant utilization, along with advanced adoption of new technologies within the industry.
   
• Provides a thorough explanation as to why doctors prefer operating on cementless partial knee prostheses for their patients.
   
• With strong requirements and preferences towards minimally invasive surgeries, allied to rapid healing post-operative protocols, this aids in explaining the rapid growth within the sales of cementless implants.
   

UK cementless partial knee implants market in Europe is projected to grow remarkably in the coming years.
 

• The usage of cementless partial knee implants in the UK is rising due to the National Health Service (NHS) focus on putting in place early intervention strategies centered on reducing more invasive surgeries such as total knee arthroplasty (TKA), improving long-term outcomes, and optimizing the use of surgical resources.
   
• Additionally, cementless partial knee replacements have drastically reduced both intraoperative and post-operative times, which is very important in the UK with its chronic surgical backlog, along with bed shortages.
• Likewise, there is an increase in investment by UK hospitals in robotic-assisted surgery systems, which enhance the precision of alignment and are beneficial for the positioning of cementless implants.
   

The Asia Pacific cementless partial knee implants market is anticipated to grow at the highest CAGR of 7.9% during the analysis timeframe.
 

• An increase in the number of cases of knee osteoarthritis is being observed in the Asia Pacific region, creating a further need for more invasive procedures like joint replacements.
   
• There is burgeoning access to international medical device companies alongside local manufacturing facilities, which also increases the availability of cementless implants.
   
• Even though the region continues to advance in comparison to the West, it stands undiscovered as a vital development frontier with immense potential.
   

China holds a dominant position in the Asia Pacific cementless partial knee implants market.
 

• The orthopedic market, specifically knee replacements, is being rapidly advanced by the aging population in China. According to China's National Bureau of Statistics, the elderly population of 65 and above will account for more than 20% of the total population by 2035.
   
• Moreover, knee osteoarthritis due to sedentary lifestyles and obesity is on the rise. This region has one of the highest prevalences of osteoarthritis among other chronic diseases. It is further exacerbated by poor urban infrastructure, which promotes physical inactivity and obesity. There is increased demand for less invasive procedures like cementless partial knee replacements, which are aimed at preserving joints.
   
• Furthermore, patients in China are increasingly willing to pay for expensive medical services given the widening middle class and growing private health insurance. As part of their marketing surgical packages, private hospitals and specialized medical centers are starting to provide options besides the traditional cemented surgeries.
   

The Brazil cementless partial knee implants market is experiencing robust growth in the Latin America market.
 

• The need for orthopedic implants is growing rapidly in the region owing to the increase in the incidence of musculoskeletal disorders, especially osteoarthritis of the knee in younger and more active Brazilians.
   
• Moreover, new opportunities for voluntary orthopedic procedures, such as partial knee replacement, are increasing owing to the rapid growth of the private sector. Elective orthopedic surgeries are also being performed at an increasing rate, such as cementless implants that improve long-term outcomes and recovery time.
   

South Africa cementless partial knee implants market is poised to witness substantial growth in the Middle East and Africa market during the forecast period.
 

• South Africa constitutes a developing and important market share in cementless partial knee implants, driven by greater healthcare utilization alongside an improved urban epidemiological profile.
   
• Greater availability of advanced surgical skills within private hospitals located in urban centers, along with patient preference for cementless implants due to their preservative, minimally invasive nature, are both working in favor of this market.
   
• Although public sector access remains constrained, continued investment in health system areas of growth, combined with an expanding middle class, supports long-term growth.
   

Cementless Partial Knee Implants Market Share

The top 5 companies in the cementless partial knee implants, such as Zimmer Biomet, Smith+Nephew, Medacta, Waldemar Link, and Amplitude Surgical, account for approximately 45% of the market share. Key players in the market are focused on patient-specific solutions, innovative biomaterials, and bone-preserving surgical techniques. Leading manufacturers in this segment are actively investing in product innovation, digital surgical planning tools, and strategic collaborations to enhance their global presence.
 

Cementless Partial Knee Implants Market Companies

Prominent players operating in the cementless partial knee implants industry include:

• amplitude SURGICAL
• GRUPPO BIOIMPIANTI
• JUST MEDICAL
• lépine
• Medacta
• Smith+Nephew
• Stryker
• Waldemar Link
• ZIMMER BIOMET
   
• Zimmer Biomet offers a comprehensive portfolio of cementless partial knee implants, such as the Persona Partial Knee Cementless System, leveraging advanced trabecular metal technology that mimics cancellous bone, ensuring excellent osseointegration and long-term fixation.
   
• Medacta sets itself apart with its GMK Uni Cementless solution, backed by the MyKnee personalized preoperative planning system, enabling surgeons to achieve highly accurate bone resections and implant positioning tailored to individual patient anatomy.
   

Cementless Partial Knee Implants Industry News:

• In January 2022, Smith+Nephew announced its acquisition of Engage Surgical, owner of a cementless unicompartmental (partial) knee system commercially available in the US. The Engage Surgical Partial Knee System is a novel, modern cementless knee implant to serve a resurgent segment driven by the potential for better long-term fixation through biologic integration and shorter operating times. This acquisition has enhanced Smith+Nephew’s product offerings in the orthopedic segment.
   

The cementless partial knee implants market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Implant Type

• Fixed-bearing implants
• Mobile-bearing implants
• Medial pivot implants
• Other implant types

Market, By Material

• Titanium-based
• Cobalt-chromium alloys
• Polyethylene components
• Other materials

Market, By End Use

• Hospitals
• Orthopedic centres
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE